EventsThe 1st International Online Conference on Xenobiotics
Published
This submission belongs to the session S3. Emerging Chemicals: Environment Risks and Health Effects of the event The 1st International Online Conference on Xenobiotics
Published date
17 Jun, 2026
Academic Editor
author-avatarLin-Chi Wang
Citation
Teresa D'Amore, Emanuela Testai, Beatrice Severino, Elisa Perissutti, Emma Di Consiglio, From Mechanisms to Decisions: Adverse Outcome Pathways Reshaping the Future of Risk Assessment, in Proceedings of The 1st International Online Conference on Xenobiotics, 22 June–23 June 2026, MDPI: Basel, Switzerland
Share
Email
Facebook
Twitter
LinkedIn

From Mechanisms to Decisions: Adverse Outcome Pathways Reshaping the Future of Risk Assessment

image
Emanuela Testai 1
image
1. Istituto Superiore di Sanità (ISS)—Italian National Institute of Health, Viale Regina Elena 299, 00161 Rome, Italy, Italy
2. Department of Pharmacy, University of Naples, Federico II, 80131 Naples, Italy
3. Department of Pharmacy, University of Naples, Federico II, 80131 Naples, Italy, Italy
Abstract

The ongoing transition toward Next-Generation Risk Assessment (NGRA) is reshaping regulatory toxicology and the risk assessment of regulated products by promoting exposure-driven, human-relevant and mechanistically informed approaches to evaluate potential risks without relying on animal testing. In this context, Adverse Outcome Pathways (AOPs) serve as a transparent and structured framework to organize mechanistic evidence and support the integration of New Approach Methodologies (NAMs) into risk assessment processes. By linking molecular initiating events to key events across biological levels and, ultimately, to adverse outcomes, AOPs provide biologically plausible and regulatorily meaningful mechanistic information. This work critically examines how AOPs and AOP networks developed by the European Food Safety Authority (EFSA) are being integrated into pesticide risk assessment. Two regulatory-relevant case studies are analyzed: (i) pesticide-induced mitochondrial dysfunction leading to Parkinson’s disease, and (ii) endocrine-disrupting mechanisms leading to uterine adenocarcinoma. For both cases, we reconstructed the AOP event flows and associated NAM batteries, assessing their scientific robustness, applicability domains, and regulatory readiness. The analysis shows that NAM-based evidence can comprehensively cover multiple key events—such as mitochondrial dysfunction, proteostasis impairment, ERα activation and epigenetic alterations—while also revealing persistent limitations, including gaps in toxicokinetic considerations, limited quantitative understanding of key event relationships, and challenges in characterizing uncertainties. Overall, our findings illustrate how AOPs can strengthen mechanistic integration, improve evidence transparency and support regulatory prioritization, while also highlighting the critical need for enhanced toxicokinetic data. In particular, further improvements —such as qAOPs and TK–TD integration— are essential to fully enable NGRA in pesticide risk assessment.

Keywords
next generation risk assessment (NGRA)
new approach methodologies (NAMs)
adverse outcome pathways (AOPs)
pesticides
regulatory toxicology
chemical risk assessment
Oral Presentation
Xenobiotic emission from indiscriminate solid waste management and risk of neurological disorders: an emerging public health concern
Xenobiotic contaminants emitted from Landfill Fires and Associated Public Health Impacts: A Systematic Review